SCRIBE BIOSCIENCES

Flexible tools for single cell analysis

ABOUT US

Scribe Biosciences is an early stage startup borne from a research collaboration between Adam Abate and Zev Gartner's labs at the UCSF to develop robust and scaleable single cell technologies.

THE SCRIBE BIOSCIENCES TEAM

RUSSELL COLE

CEO & Co-founder

MAITHREYAN SRINIVASAN

CSO

JUSTIN MADRIGAL

Project scientist

WHAT WE DO

Our fundamental technology, Printed Droplet Microfluidics (PDM), is a flexible and reconfigurable fluid handling system to perform picoliter-scale manipulations. By leveraging fluorescence-activated microfluidic droplet sorting and a specialized substrate, PDM enables the flexible and deterministic handling of single cells and fluid aliquots at extremely high throughputs.

Scribe is currently working under a SBIR research contract from the DARPA INTERCEPT program to adapt PDM technology for single cell virology applications.